Status:
COMPLETED
Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Dutch Health Care Insurance Board
Conditions:
Chronic Otitis Media
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
Chronic suppurative otitis media is one of the most common chronic infections in children worldwide. Symptoms include otorrhea, otalgia and hearing loss. In many countries, it is treated primarily wit...
Detailed Description
Chronic suppurative otitis media is one of the most common chronic infections in children worldwide. Symptoms include otorrhea, otalgia and hearing loss. In many countries it is treated primarily with...
Eligibility Criteria
Inclusion
- age between 1 and 12 years
- otorrhea for more than 3 months
Exclusion
- cholesteatoma
- known immune deficiency other than IgA or IgG2
- Down's syndrome
- craniofacial anomalies
- cystic fibrosis
- immotile cilia syndrome
- allergy to sulfamethoxazole-trimethoprim
- continuous use of sulfamethoxazole-trimethoprim for more than six weeks in the past six months
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00189098
Start Date
February 1 2003
End Date
November 1 2006
Last Update
July 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilhelmina Children Hospital, University Medical Center Utrecht
Utrecht, Utrecht, Netherlands, 3508AB